Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer

被引:18
|
作者
Meyer, K
Beyene, A
Bowlin, TL
Basu, A
Ray, R
机构
[1] St Louis Univ, Dept Internal Med, Div Infect Dis & Immunol, St Louis, MO 63110 USA
[2] St Louis Univ, Dept Mol Microbiol & Immunol, Div Infect Dis & Immunol, St Louis, MO 63110 USA
[3] Microbiotix Inc, Worcester, MA USA
关键词
D O I
10.1128/JVI.78.23.12838-12847.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have previously reported that a pseudotype virus generated by reconstitution of hepatitis C virus (HCV) chimeric envelope glycoprotein E1-G or E2-G on the surface of a temperature- sensitive mutant of vesicular stomatitis virus (VSVts045) interacts independently with mammalian cells to initiate infection. Here, we examined whether coexpression of both of the envelope glycoproteins on pseudotype particles would augment virus infectivity and/or alter the functional properties of the individual subunits. Stable transfectants of baby hamster kidney (BHK) epithelial cells expressing either one or both of the chimeric envelope glycoproteins of HCV on the cell surface were generated. The infectious titer of the VSV pseudotype, derived from a stable cell line incorporating both of the chimeric glycoproteins of HCV, was similar to4- to 5-fold higher than that of a pseudotype bearing E1-G alone or similar to25- to 30-fold higher than that of E2-G alone when assayed with a number of mammalian cell lines. Further studies suggested that that the E1-G/E2-G or E2-G pseudotype was more sensitive to the inhibitory effect of heparin than the E1-G pseudotype. Treatment of the E1-G/E2-G pseudotype with a negatively charged sulfated sialyl lipid (NMS03) displayed a similar to4-fold-higher sensitivity to neutralization than pseudotypes with either of the two individual glycoproteins. In contrast, VSVts045, used as a backbone for the generation of pseudotypes, displayed at least 20-fold-higher sensitivity to NMS03-mediated inhibition of virus plaque formation. The effect of low-density lipoprotein on the E1-G pseudotype was greater than that apparent for the E1-G/E2-G pseudotype. The treatment of cells with monoclonal antibodies to CD81 displayed an inhibitory effect upon the pseudotype with E1-G/E2-G or with E2-G alone. Taken together, our results indicate that the HCV El and E2 glycoproteins have separable functional properties and that the presence of these two envelope glycoproteins on VSV/HCV pseudotype particles increases infectious titer.
引用
收藏
页码:12838 / 12847
页数:10
相关论文
共 50 条
  • [41] The Neutralizing Face of Hepatitis C virus E2 envelope Glycoprotein
    Tzarum, Netanel
    Wilson, Ian A.
    Law, Mansun
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [42] Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
    Kong, Leopold
    Giang, Erick
    Nieusma, Travis
    Kadam, Rameshwar U.
    Cogburn, Kristin E.
    Hua, Yuanzi
    Dai, Xiaoping
    Stanfield, Robyn L.
    Burton, Dennis R.
    Ward, Andrew B.
    Wilson, Ian A.
    Law, Mansun
    SCIENCE, 2013, 342 (6162) : 1090 - 1094
  • [43] Immunoglobulin mimicry by hepatitis C virus envelope protein E2
    Hu, YW
    Rocheleau, L
    Larke, B
    Chui, L
    Lee, B
    Ma, M
    Liu, S
    Omlin, T
    Pelchat, M
    Brown, EG
    VIROLOGY, 2005, 332 (02) : 538 - 549
  • [44] Production and characterization of the ectodomain of E2 envelope glycoprotein of hepatitis C virus folded in the presence of full-length E1 glycoprotein
    Ortega-Atienza, Sara
    Lombana, Laura
    Gomez-Gutierrez, Julian
    Yelamos, Belen
    Peterson, Darrell L.
    Gavilanes, Francisco
    PROTEIN EXPRESSION AND PURIFICATION, 2014, 104 : 20 - 25
  • [45] Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis
    Genovese, D
    Dettori, S
    Argentini, C
    Villano, U
    Chionne, P
    Angelico, M
    Rapicetta, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) : 1902 - 1909
  • [46] Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly
    Tong, Yimin
    Lavillette, Dimitri
    Li, Qingchao
    Zhong, Jin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [47] Rubella virus pseudotypes and a cell-cell fusion assay as tools for functional analysis of the rubella virus E2 and E1 envelope glycoproteins
    Claus, Claudia
    Hofmann, Joerg
    Uberla, Klaus
    Liebert, U. G.
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 3029 - 3037
  • [48] Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins
    Abraham, JD
    Himoudi, N
    Kien, F
    Berland, JL
    Codran, A
    Bartosch, B
    Baumert, T
    Paranhos-Baccala, G
    Schuster, C
    Inchauspé, G
    Kieny, MP
    VACCINE, 2004, 22 (29-30) : 3917 - 3928
  • [49] Host–pathogen interactome analysis of Chikungunya virus envelope proteins E1 and E2
    Namrata Dudha
    Jyoti Rana
    Sreejith Rajasekharan
    Reema Gabrani
    Amita Gupta
    Vijay Kumar Chaudhary
    Sanjay Gupta
    Virus Genes, 2015, 50 : 200 - 209
  • [50] Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus
    Migliaccio, CT
    Follis, KE
    Matsuura, Y
    Nunberg, JH
    VIRUS RESEARCH, 2004, 105 (01) : 47 - 57